Auerbach M - Search Results

1

Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.

Auerbach M, Pappadakis JA, Bahrain H, Auerbach SA, Ballard H, Dahl NV. Auerbach M, et al. Among authors: auerbach sa. Am J Hematol. 2011 Oct;86(10):860-2. doi: 10.1002/ajh.22153. Epub 2011 Aug 29. Am J Hematol. 2011. PMID: 21922526 Free article. No abstract available.

2

Clinical use of the total dose intravenous infusion of iron dextran.

Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, Ballard H. Auerbach M, et al. J Lab Clin Med. 1988 May;111(5):566-70. J Lab Clin Med. 1988. PMID: 3361236

3

Management of the severely anemic Jehovah's Witness.

Auerbach M, Ballard H. Auerbach M, et al. Ann Intern Med. 1993 Jul 15;119(2):169; author reply 170. doi: 10.7326/0003-4819-119-2-199307150-00018. Ann Intern Med. 1993. PMID: 8347238 No abstract available.

4

Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: a double blind randomized trial.

Auerbach M, Chaudhry M, Goldman H, Ballard H. Auerbach M, et al. J Lab Clin Med. 1998 Mar;131(3):257-60. doi: 10.1016/s0022-2143(98)90098-1. J Lab Clin Med. 1998. PMID: 9523850 Clinical Trial.

5

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.

Auerbach M, Ballard H, Trout JR, McIlwain M, Ackerman A, Bahrain H, Balan S, Barker L, Rana J. Auerbach M, et al. J Clin Oncol. 2004 Apr 1;22(7):1301-7. doi: 10.1200/JCO.2004.08.119. J Clin Oncol. 2004. PMID: 15051778 Clinical Trial.

6

Reexamination of the need for treatment in Idiopathic Thrombocytopenic Purpura.

Auerbach M, Ballard H. Auerbach M, et al. Am J Hematol. 2006 Oct;81(10):803. doi: 10.1002/ajh.20584. Am J Hematol. 2006. PMID: 16783784 Free article. No abstract available.

7

Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.

Henry DH, Dahl NV, Auerbach M, Tchekmedyian S, Laufman LR. Henry DH, et al. Among authors: auerbach m. Oncologist. 2007 Feb;12(2):231-42. doi: 10.1634/theoncologist.12-2-231. Oncologist. 2007. PMID: 17296819 Free article. Clinical Trial.

8

Clinical update: intravenous iron for anaemia.

Auerbach M, Ballard H, Glaspy J. Auerbach M, et al. Lancet. 2007 May 5;369(9572):1502-1504. doi: 10.1016/S0140-6736(07)60689-8. Lancet. 2007. PMID: 17482969 No abstract available.

9

Intravenous iron: from anathema to standard of care.

Auerbach M, Coyne D, Ballard H. Auerbach M, et al. Am J Hematol. 2008 Jul;83(7):580-8. doi: 10.1002/ajh.21154. Am J Hematol. 2008. PMID: 18273906 Free article. Review.

10

Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease.

Auerbach M, Al Talib K. Auerbach M, et al. Kidney Int. 2008 Mar;73(5):528-30. doi: 10.1038/sj.ki.5002779. Kidney Int. 2008. PMID: 18274543 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

460 results

Search Page